McKesson (NYSE:MCK) Issues FY 2026 Earnings Guidance

Key Points

• McKesson updated its FY 2026 earnings guidance, expecting earnings per share (EPS) between $37.100 and $37.900, slightly below the consensus estimate of $37.352.
• The company increased its quarterly dividend to $0.82 per share, up from $0.71, with a yield of 0.5% and a payout ratio of 11.32%.
• Several analysts recently upgraded their price targets for McKesson, with ranges now set between $800.00 and $810.00, reflecting strong confidence in the stock.

McKesson (NYSE:MCK - Get Free Report) issued an update on its FY 2026 earnings guidance on Saturday morning. The company provided earnings per share (EPS) guidance of 37.100-37.900 for the period, compared to the consensus estimate of 37.352. The company issued revenue guidance of -.

Analyst Ratings Changes

Several research firms have commented on MCK. Bank of America raised their target price on shares of McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Cowen reaffirmed a "buy" rating on shares of McKesson in a research report on Thursday, August 7th. Wall Street Zen downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Sunday, July 13th. Evercore ISI boosted their price objective on shares of McKesson from $760.00 to $800.00 and gave the company an "outperform" rating in a research report on Wednesday, July 9th. Finally, UBS Group boosted their price objective on shares of McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $725.10.

McKesson Trading Up 0.4%

NYSE:MCK traded up $2.6240 during trading hours on Thursday, hitting $705.5640. 325,539 shares of the company traded hands, compared to its average volume of 886,542. The stock has a market capitalization of $87.76 billion, a price-to-earnings ratio of 28.15, a P/E/G ratio of 1.35 and a beta of 0.50. McKesson has a twelve month low of $464.42 and a twelve month high of $737.89. The firm has a 50-day moving average of $707.96 and a 200 day moving average of $683.29.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.33 by ($0.07). McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business had revenue of $97.83 billion during the quarter, compared to analyst estimates of $95.93 billion. During the same quarter in the prior year, the company posted $7.88 EPS. The company's quarterly revenue was up 23.4% compared to the same quarter last year. Equities research analysts predict that McKesson will post 32.77 earnings per share for the current fiscal year.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Tuesday, September 2nd will be issued a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 2nd. This is a positive change from McKesson's previous quarterly dividend of $0.71. McKesson's payout ratio is currently 11.32%.

Insiders Place Their Bets

In other McKesson news, EVP Thomas L. Rodgers sold 2,891 shares of the stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $712.18, for a total transaction of $2,058,912.38. Following the sale, the executive vice president owned 2,544 shares of the company's stock, valued at $1,811,785.92. This represents a 53.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the completion of the sale, the chief accounting officer owned 657 shares of the company's stock, valued at $436,031.19. The trade was a 33.37% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 56,620 shares of company stock worth $39,712,388 in the last quarter. 0.08% of the stock is owned by corporate insiders.

Institutional Trading of McKesson

Institutional investors have recently made changes to their positions in the business. State of Wyoming bought a new stake in shares of McKesson in the second quarter worth $29,000. Osterweis Capital Management Inc. bought a new stake in McKesson during the second quarter worth $166,000. Vivaldi Capital Management LP bought a new stake in McKesson during the second quarter worth $205,000. Caxton Associates LLP acquired a new position in shares of McKesson in the first quarter valued at $233,000. Finally, Diversify Advisory Services LLC acquired a new position in shares of McKesson in the second quarter valued at $237,000. Institutional investors own 85.07% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.